Picture Berlin Partner Top News EIC Accelerator Noah Labs MyoPax 650x100px

Organisation › Details

Saiba Animal Health AG

LinkedIn: https://www.linkedin.com/company/saiba-animal-health

Saiba Animal Health AG, founded in 2013 as a spin-off from the University of Zurich, Switzerland, has developed a broad and innovative pipeline of Virus-Like Particles (VLP)-based therapeutic vaccines targeting major unmet medical needs in veterinary medicine. *

	Start	2013-01-01 established (s-off)
	Group	Boehringer Ingelheim (Group)
	Industry	animal health
	Industry 2	animal vaccine

	Region	Zürich ZH
	Country	Switzerland
	Street	13 Bahnhofstr. Pfäffikon
	City	8808 Pfäffikon, Zürich
		Address record changed: 2024-09-04

Basic data	Employees	n. a.

		* Document for »About Section«: Boehringer Ingelheim. (9/3/24). "Press Release: Boehringer Ingelheim Acquires Saiba Animal Health, Adding Innovative Technology Platform to Its Pet Therapeutics R&D Portfolio". Ingelheim.

		Record changed: 2024-12-29

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Boehringer Ingelheim (Group)

[1] Boehringer Ingelheim. (1/16/25). "Press Release: Boehringer Provides Update on Iclepertin Phase III Program in Schizophrenia". Ingelheim....
[2] Boehringer Ingelheim. (10/9/24). "Press Release: Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment". Ingelheim & South San Francisco, CA....
[3] Boehringer Ingelheim Stiftung / ÖAW. (9/18/24). "Press Release: OeAW and Boehringer Ingelheim Foundation Establish New Institute for Biomedical Artificial Intelligence in Vienna". Mainz....
[4] Boehringer Ingelheim. (9/3/24). "Press Release: Boehringer Ingelheim Acquires Saiba Animal Health, Adding Innovative Technology Platform to Its Pet Therapeutics R&D Portfolio". Ingelheim....
[5] Boehringer Ingelheim. (8/30/24). "Press Release: Boehringer Ingelheim Announces Appointments Board of Managing Directors". Ingelheim....
[6] Boehringer Ingelheim. (8/27/24). "Press Release: Boehringer Ingelheim to Unveil Groundbreaking oncology Research at WCLC, Demonstrating Strength of Portfolio". Ingelheim....
[7] Shenzhen Synthetica Pioneering Co., Ltd.. (7/30/24). "Press Release: Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors". Shenzhen....
[8] Boehringer Ingelheim. (7/29/24). "Press Release: CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for Spevigo". Ingelheim & La Jolla, CA....
[9] Boehringer Ingelheim. (7/29/24). "Press Release: Boehringer Ingelheim Secures Novel Immune Checkpoint Inhibitor with Acquisition of Nerio Therapeutics". Ingelheim & La Jolla, CA....
[10] Quantro Therapeutics GmbH. (6/4/24). "Press Release: Quantro Therapeutics Reaches a Milestone in the Collaboration with Boehringer Ingelheim to Develop First-in-Class Cancer Treatments". Vienna....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]